➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Mallinckrodt
AstraZeneca

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Patent: 4,315,998

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,315,998
Title: Polymer-bound photosensitizing catalysts
Abstract:Polymer-bound photosensitizing catalysts are effective in the heterogeneous catalysis of various photosensitized chemical reactions, such as photooxidation reactions, photodimerization reactions, and photocycloaddition reactions, and are thereafter readily separated from the reaction medium and reaction products by simple filtration. The polymer-bound photosensitizing catalysts comprise the nucleophilic displacement reaction product of (A) a polymeric material having attached thereto an available leaving group which is capable of being displaced in a nucleophilic displacement reaction with a nucleophilic reagent and (B) a photosensitizing catalytic compound containing in its molecule a nucleophile which is capable of displacing the leaving group attached to the polymeric material in a nucleophilic displacement reaction.
Inventor(s): Neckers; Douglas C. (Bowling Green, OH), Blossey; Erich C. (Winter Park, FL), Schaap; A. Paul (Detroit, MI)
Assignee: Research Corporation (New York, NY)
Application Number:06/009,713
Patent Claims:see list of patent claims

Details for Patent 4,315,998

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Recordati Rare Diseases, Inc. PANHEMATIN hemin POWDER, FOR SOLUTION 101246 1 1983-07-20   Start Trial Research Corporation (New York, NY) 2040-01-28 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Mallinckrodt
AstraZeneca
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.